Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Amulet vs LAmbre: Left Atrial Appendage Closure in NVAF patients at high bleeding risk

Official title: Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure: the CALAMBRE Randomized Clinical Trial

Run by Fundación EPIC · NCT07260474 · Data updated 2026-11-12

This study tests whether the Amplatzer Amulet or the LAmbre device works better for closing the left atrial appendage in adults with non-valvular atrial fibrillation who are at high risk of stroke and bleeding.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorFundación EPIC
Academic / other
Locations1 site (Fuencarral-El Pardo)
StatusRecruiting
StartedMay 5, 2024
Main results expectedDecember 31, 2026
Study endsJanuary 31, 2027
Registry record updatedOctober 7, 2026
Trial IDNCT07260474 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with non-valvular atrial fibrillation, CHA2DS2-VASc ≥2, and at least one Munich-consensus high-bleeding-risk criterion, suitable for either device after preprocedural imaging.

Probably not a fit

Patients who do not meet inclusion criteria, have contraindications to the devices, or have factors leading to high risk of adverse events may derive no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this multicenter, prospective, randomized trial, adults with non-valvular atrial fibrillation at high embolic and bleeding risk are assigned to left atrial appendage closure using either the Amplatzer Amulet or the LAmbre device. The trial compares implantation success, the degree of appendage closure, and clinical outcomes during follow-up. All participants undergo preprocedural imaging to confirm suitability for closure and absence of LAA thrombus. CE-marked devices are used under controlled, ethical conditions with informed consent and standard safety monitoring.

Why it matters

Potential benefit: If successful, the study could clarify which device provides safer and more reliable closure, potentially reducing stroke risk for high-risk patients.

How similar studies have gone: Earlier experiences with left atrial appendage closure devices have shown benefits in selected populations, but direct, randomized comparisons like this are less common.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

(MUST MEET ALL INCLUSION CRITERIA)

* Patient with aged ≥18 years AND;
* Patient have non-valvular atrial (NVAF) with a CHA2DS2-VASc score ≥2, and presented at least one high-bleeding-risk criterion according to the Munich consensus document AND;
* Patient are required to undergo preprocedural TEE / CCTA to confirm the absence of LAA thrombus and to ensure that LAA anatomy is suitable for closure with either device.
* Patient who has been informed of the characteristics of the study and has provided written informed consent..

Exclusion Criteria:

(MUST NOT MEET ANY EXCLUSION CRITERIA)

* Patient life expectancy \<1 year (terminal illness).
* Patient with requirement for oral anticoagulation therapy for any indication other than non-valvular atrial fibrillation.
* Patient with prior surgical ligation or obliteration of the left atrial appendage.
* Patient with history of allergic reaction or intolerance to any material used in the study devices or to any of the antithrombotic agents required post-procedure.
* Patient with active systemic infection.
* Patient with concurrent participation in another investigational study that may affect study results.
* Patient with inability or unwillingness to comply with the study protocol or follow-up requirements.
* Patient pregnant or breastfeeding women.

Where it's running

  • Hospital Universitario La Paz
    Fuencarral-El Pardo, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.